Correlations between Gene Amplification and Protein Expression of
Topoisomerase 2A (TOP2A) in Squamous Cell Carcinoma of the Lung
Anita Modi1, MSII, and Charalambos C. Solomides2, MD
1Jefferson

Medical College at Thomas Jefferson University; 2Department of Pathology, Thomas Jefferson University Hospital, Philadelphia, PA

ABSTRACT

METHODS

Background: While DNA topoisomerase 2A (TOP2A) plays an essential role in maintaining the
structural integrity of the double helix during replication and recombination, excessive expression
of this enzyme may promote malignant cell transformations. In fact, increased levels of TOP2A
have been observed in various cancer cell lines including squamous cell carcinoma of the lung.
This study sought to identify correlations between genotypic and phenotypic evidence of TOP2A
obtained via in situ hybridization (ISH) and immunohistochemistry (IHC) techniques.
Methods Tissue microarrays created from 29 samples of Stage I Squamous Cell Carcinoma of
the lung were stained with VENTANA BenchMark ULTRA platform with dual color ISH molecular
probes TOP2A / CEP17 and antiTOP2A antibody (clone JS5B4-rabbit monoclonal antibody).
Gene copy numbers were analyzed using bright field microscopy. Gene amplification was
considered in cells exhibiting gene copies > 3 or TOP2A:CEP17 ratios > 1.82. IHC stains were
quantified using Spectrum software (Apeiro technologies) using the nuclear algorithm. All levels of
protein expression (+1 to +3) were considered positive.
Results: A moderate Pearson Correlation (0.4) between TOP2A gene amplification and protein
expression was identified.
Conclusion: While gene amplification moderately correlated with protein expression of TOP2A,
additional factors influencing protein expression independently of gene amplification should be
identified.
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INTRODUCTION

Tissue microarrays
(TMAs) were created
using 29 tissue
samples of Stage I
Squamous Cell
Carcinoma of the Lung.
Cores were resected at
TJUH in 1996/97.

Quantification: Spectrum labeled nuclei
based on TOP2A expression

Statistical analyses were conducted on the data obtained through the staining and quantification processes and compiled as shown in the
following tables. A moderate Pearson Correlation (0.4) was observed.

 

CONCLUSIONS
• TOP2A protein expression moderately correlates with TOP2A gene amplification in
squamous cell carcinoma of the lung (Pearson Correlation: 0.4).
• Additional factors influencing the TOP2A protein expression independently of TOP2A gene
amplification should be identified.
• Verification of TOP2A protein expression may not substitute for that of TOP2A gene
amplification.

TOP2A (gene copies)
CEP17 (centromeres)

Staining:
•
VENTANA BenchMark ULTRA platform
•
Dual color ISH molecular probes
Quantification:
•
Bright field microscopy:
20-40 cells quantified per section
•
Recorded values per cell for each section:
Average number of gene copies
TOP2A:CEP17 ratio
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RESULTS

  

In situ hybridization (ISH) identified nuclear TOP2A gene copies, centromeres.

Immunohistochemistry (IHC) detected nuclear TOP2A protein expression, quantified with Spectrum Software (Apeiro technologies).

Staining: VENTANA antiTOP2A antibody
to nuclear TOP2A protein

While DNA topoisomerase 2A (TOP2A) plays an
essential role in maintaining the structural integrity of
the double helix during replication and recombination,
excessive expression of this enzyme may promote
malignant cell transformations.
TOP2A protein expression has been correlated with
poorer prognoses in breast cancer, as well as small
cell and squamous cell carcinomas of the lung.
TOP2A gene amplification has been correlated with
increased responses and reduced resistance to
targeted therapies for breast cancer. However, the
relationship between gene amplification and protein
expression in squamous cell carcinoma is unknown.
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Gene amplification:
Gene copies > 3, TOP2A:CEP17 > 1.82

Protein expression:
TOP2A protein > 0

In both tables to the right,
TOP2A-amplified tumor cells
were positive for nuclear
TOP2A protein at all levels of
expression more consistently
than non-amplified tumor
cells. This trend is especially
pronounced when comparing
high levels of protein
expression between amplified
and non-amplified cells on the
basis of TOP2A:CEP17 ratios
(Table 2).However, some
cases that didn’t demonstrate
TOP2A gene amplification
expressed TOP2A protein and
vice versa.
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